Explore 8 court opinions on Patentability Of Diagnostic Methods. AI-powered plain English summaries, key holdings, and legal analysis.
8 recent cases analyzed in this topic area.
Federal Circuit Affirms PTAB's Patent Invalidation for Abstract Idea
Mutakaber v. Secretary of State, decided by Federal Circuit on December 18, 2025, resulted in a defendant win outcome. The case concerns the validity of a patent for a "method and apparatus for detect...
Federal Circuit Affirms Patent Ineligibility of Genetic Diagnostic Method
Golden v. Collins, decided by Federal Circuit on December 12, 2025, resulted in a defendant win outcome. The case concerns the patentability of a diagnostic method for identifying a specific genetic m...
Federal Circuit Affirms Patent Ineligibility of Nucleic Acid Detection Method
Fisher v. United States, decided by Federal Circuit on August 12, 2025, resulted in a defendant win outcome. The case concerns the patentability of a method for detecting and quantifying nucleic acid ...
Federal Circuit Affirms PTAB's Rejection of Patent for Abstract Idea
Beacon Point Associates LLC v. DVA, decided by Federal Circuit on June 5, 2025, resulted in a defendant win outcome. The case concerns whether a patent for a "method of treating a patient" was properl...
Federal Circuit Affirms PTAB's Denial of IPR Institution
In Re KOSTIC, decided by Federal Circuit on May 6, 2025, resulted in a defendant win outcome. The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) decision to deny institution of an...
CAFC Affirms PTAB's § 101 Rejection of Nucleic Acid Detection Method
Hatfield v. Collins, decided by Federal Circuit on May 2, 2025, resulted in a defendant win outcome. The case concerns the patentability of a method for detecting and quantifying nucleic acid sequence...
SCOTUS Clarifies Patent Eligibility: 'All Elements' Test Doesn't Require Inventive Additions
Bondi v. Vanderstok, decided by Supreme Court of the United States on March 26, 2025, resulted in a affirmed outcome. The Supreme Court affirmed the Ninth Circuit's decision, holding that the "all ele...
Federal Circuit: Off-label drug use methods not patentable under § 101
In Re RIGGS, decided by Federal Circuit on March 24, 2025, resulted in a defendant win outcome. The case concerns the patentability of a method for treating a patient with a "disease or condition" usi...